Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Baixin'an: Subsidiary Iberis®RDN System Successfully Registered in Thailand
Recently, Baixin’an announced that its subsidiary, Shanghai Antong Medical Technology Co., Ltd., has completed registration in Thailand for the Iberis® Multi-polar Renal Artery Radiofrequency Ablation System.
This registration was supported by Bosung International Group Co., Ltd., marking a further expansion of the Iberis® RDN system into the international market.
Antong and Bosung have formed a strategic partnership, covering multiple regions including but not limited to EU countries, Asia-Pacific, and Latin America.
The Iberis® RDN system is the world’s only approved renal nerve blockade product that uses both transradial and transfemoral approaches, aiming to provide safer and more effective outpatient RDN procedures worldwide. The company has obtained CE marking for the Iberis® RDN system in Europe since 2016.
(Baixin’an - Announcement B)
(Edited by: Yang Yan, Lin Chen)
Keywords: Medical